scispace - formally typeset
D

Diego Albani

Researcher at Mario Negri Institute for Pharmacological Research

Publications -  190
Citations -  13004

Diego Albani is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Bipolar disorder & Population. The author has an hindex of 35, co-authored 178 publications receiving 10355 citations. Previous affiliations of Diego Albani include National Research Council.

Papers
More filters
Journal ArticleDOI

Systematic Analysis of Injectable Materials and 3D Rapid Prototyped Magnetic Scaffolds: From CNS Applications to Soft and Hard Tissue Repair/Regeneration

TL;DR: In this article, the rheological and functional features of hydrogel-based materials for central nervous system applications or soft tissue regeneration (collagen/PEG semi-IPNs) as well as for hard tissue engineering (alginate/iron-doped hydroxyapatite) were evaluated.
Journal ArticleDOI

Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.

TL;DR: The influence of GRN genetic variability on susceptibility to Alzheimer's disease and on expression levels in a series of neuropathologically-confirmed AD patients as well as in peripheral mononuclear cells (PBMC) and in cells isolated from cerebrospinal fluid (CSF) was investigated as discussed by the authors.
Journal ArticleDOI

Body mass index, lifestyles, physical performance and cognitive decline: the "Treviso Longeva (TRELONG)" study.

TL;DR: Age and higher baseline BMI, independent of gender, and other confounding factors, are risk factors for cognitive decline and reading habit plays a protective role seven years later among northern Italian adults aged 70 years or older.
Journal ArticleDOI

Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2.

TL;DR: It is found that α-synOs abolished mouse memory establishment in association to hippocampal glial activation, and the oligomer-mediated detrimental actions are TLR2 dependent, the involvement of TLR4 was ruled out.